Human Microbiome Market Size to Worth Around USD 1,700 Million by 2027
The report analyzes and forecasts the Human Microbiome Market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2022 to 2030. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Human Microbiome Market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Human Microbiome Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Human Microbiome Market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/2430
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
Market Players as below:
The global human microbiome market includes prominent players such as Merck, Yakult, DuPont, Enterome Bioscience, ViThera Pharmaceuticals, Second Genome Inc., Vedanta BioSciences, Microbiome Therapeutics LLC, Osel, Metabiomics Corporation, and others. The most adopted approach in the global human microbiome market has been patent and licence approvals.
The major market segments of Human Microbiome Market are as below:
Human Microbiome Market By Product
Probiotics
Prebiotics
Medical Foods
Diagnostic Device
Drugs
Supplements
Human Microbiome Market By Disease
Obesity
Diabetes
Autoimmune Disorders
Cancer
Mental Disorders
Others
Human Microbiome Market By Application
Therapeutics
Diagnostics
Ask Query Here: richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
Table Of Contents:
CHAPTER 1. Industry Overview of Human Microbiome
1.1. Definition and Scope
1.1.1. Definition of Human Microbiome
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Human Microbiome Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Human Microbiome Market By Product Type
1.2.3. Human Microbiome Market By Disease Type
1.2.4. Human Microbiome Market By Application
1.2.5. Human Microbiome Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Human Microbiome Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Human Microbiome Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Proportion of Manufacturing Cost Structure
3.8.1.1. Raw Material
3.8.1.2. Labor Cost
3.8.1.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Human Microbiome Market By Product Type
4.1. Introduction
4.2. Human Microbiome Revenue By Product Type
4.2.1. Human Microbiome Revenue (US$ Mn) and Forecast, By Product Type, 2016-2027
4.2.2. Probiotics
4.2.2.1. Probiotics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Prebiotics
4.2.3.1. Prebiotics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Medical Foods
4.2.4.1. Medical Foods Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5. Diagnostic Device
4.2.5.1. Diagnostic Device Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.6. Drugs
4.2.6.1. Drugs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.7. Supplements
4.2.7.1. Supplements Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 5. Human Microbiome Market Revenue By Disease Type
5.1. Introduction
5.2. Human Microbiome Revenue (US$ Mn) By Disease Type
5.2.1. Human Microbiome Revenue (US$ Mn) and Forecast By Disease Type, 2016 – 2027
5.2.2. Obesity
5.2.2.1. Obesity Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Diabetes
5.2.3.1. Diabetes Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Autoimmune Disorders
5.2.4.1. Autoimmune Disorders Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Cancer
5.2.5.1. Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.6. Mental Disorders
5.2.6.1. Mental Disorders Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.7. Others
5.2.7.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Human Microbiome Market By Application
6.1. Introduction
6.2. Human Microbiome Revenue (US$ Mn) By Application
6.2.1. Human Microbiome Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
6.2.2. Therapeutics
6.2.2.1. Therapeutics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Diagnostics
6.2.3.1. Diagnostics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. North America Human Microbiome Market By Country
7.1. North America Human Microbiome Overview
7.2. U.S.
7.2.1. U.S. Human Microbiome Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
7.2.2. U.S. Human Microbiome Market Revenue (US$ Mn) and Forecast By Disease Type, 2016-2027
7.2.3. U.S. Human Microbiome Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.3. Canada
7.3.1. Canada Human Microbiome Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
7.3.2. Canada Human Microbiome Market Revenue (US$ Mn) and Forecast By Disease Type, 2016-2027
7.3.3. Canada Human Microbiome Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.4. North America PEST Analysis
CHAPTER 8. Europe Human Microbiome Market By Country
8.1. Europe Human Microbiome Market Overview
8.2. U.K.
8.2.1. U.K. Human Microbiome Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
8.2.2. U.K. Human Microbiome Market Revenue (US$ Mn) and Forecast By Disease Type, 2016-2027
8.2.3. U.K. Human Microbiome Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.3. Germany
8.3.1. Germany Human Microbiome Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
8.3.2. Germany Human Microbiome Market Revenue (US$ Mn) and Forecast By Disease Type, 2016-2027
8.3.3. Germany Human Microbiome Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.4. France
8.4.1. France Human Microbiome Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
8.4.2. France Human Microbiome Market Revenue (US$ Mn) and Forecast By Disease Type, 2016-2027
8.4.3. France Human Microbiome Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.5. Spain
8.5.1. Spain Human Microbiome Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
8.5.2. Spain Human Microbiome Market Revenue (US$ Mn) and Forecast By Disease Type, 2016-2027
8.5.3. Spain Human Microbiome Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.6. Rest of Europe
8.6.1. Rest of Europe Human Microbiome Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
8.6.2. Rest of Europe Human Microbiome Market Revenue (US$ Mn) and Forecast By Disease Type, 2016-2027
8.6.3. Rest of Europe Human Microbiome Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Human Microbiome Market By Country
9.1. Asia Pacific Human Microbiome Market Overview
9.2. China
9.2.1. China Human Microbiome Market Revenue (US$ Mn) and Forecast By Product Type, 2016 – 2027
9.2.2. China Human Microbiome Market Revenue (US$ Mn) and Forecast By Disease Type, 2016 – 2027
9.2.3. China Human Microbiome Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
9.3. Japan
9.3.1. Japan Human Microbiome Market Revenue (US$ Mn) and Forecast By Product Type, 2016 – 2027
9.3.2. Japan Human Microbiome Market Revenue (US$ Mn) and Forecast By Disease Type, 2016 – 2027
9.3.3. Japan Human Microbiome Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
9.4. India
9.4.1. India Human Microbiome Market Revenue (US$ Mn) and Forecast By Product Type, 2016 – 2027
9.4.2. India Human Microbiome Market Revenue (US$ Mn) and Forecast By Disease Type, 2016 – 2027
9.4.3. India Human Microbiome Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
9.5. Australia
9.5.1. Australia Human Microbiome Market Revenue (US$ Mn) and Forecast By Product Type, 2016 – 2027
9.5.2. Australia Human Microbiome Market Revenue (US$ Mn) and Forecast By Disease Type, 2016 – 2027
9.5.3. Australia Human Microbiome Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
9.6. South Korea
9.6.1. South Korea Human Microbiome Market Revenue (US$ Mn) and Forecast By Product Type, 2016 – 2027
9.6.2. South Korea Human Microbiome Market Revenue (US$ Mn) and Forecast By Disease Type, 2016 – 2027
9.6.3. South Korea Human Microbiome Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Human Microbiome Market Revenue (US$ Mn) and Forecast By Product Type, 2016 – 2027
9.7.2. Rest of Asia-Pacific Human Microbiome Market Revenue (US$ Mn) and Forecast By Disease Type, 2016 – 2027
9.7.3. Rest of Asia-Pacific Human Microbiome Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Human Microbiome Market By Country
10.1. Latin America Human Microbiome Market Overview
10.2. Brazil
10.2.1. Brazil Human Microbiome Market Revenue (US$ Mn) and Forecast By Product Type, 2016 – 2027
10.2.2. Brazil Human Microbiome Market Revenue (US$ Mn) and Forecast By Disease Type, 2016 – 2027
10.2.3. Brazil Human Microbiome Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.3. Mexico
10.3.1. Mexico Human Microbiome Market Revenue (US$ Mn) and Forecast By Product Type, 2016 – 2027
10.3.2. Mexico Human Microbiome Market Revenue (US$ Mn) and Forecast By Disease Type, 2016 – 2027
10.3.3. Mexico Human Microbiome Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.4. Rest of Latin America
10.4.1. Rest of Latin America Human Microbiome Market Revenue (US$ Mn) and Forecast By Product Type, 2016 – 2027
10.4.2. Rest of Latin America Human Microbiome Market Revenue (US$ Mn) and Forecast By Disease Type, 2016 – 2027
10.4.3. Rest of Latin America Human Microbiome Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Human Microbiome Market By Country
11.1. Middle East & Africa Human Microbiome Market Overview
11.2. Saudi Arabia
11.2.1. Saudi Arabia Human Microbiome Market Revenue (US$ Mn) and Forecast By Product Type, 2016 – 2027
11.2.2. Saudi Arabia Human Microbiome Market Revenue (US$ Mn) and Forecast By Disease Type, 2016 – 2027
11.2.3. Saudi Arabia Human Microbiome Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
11.3. UAE
11.3.1. UAE Human Microbiome Market Revenue (US$ Mn) and Forecast By Product Type, 2016 – 2027
11.3.2. UAE Human Microbiome Market Revenue (US$ Mn) and Forecast By Disease Type, 2016 – 2027
11.3.3. UAE Human Microbiome Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Human Microbiome Market Revenue (US$ Mn) and Forecast By Product Type, 2016 – 2027
11.4.2. Rest of Middle East & Africa Human Microbiome Market Revenue (US$ Mn) and Forecast By Disease Type, 2016 – 2027
11.4.3. Rest of Middle East & Africa Human Microbiome Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Human Microbiome
12.1. Human Microbiome Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Human Microbiome Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. COMPANY PROFILE
13.1. Merck KgaA
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2019
13.1.3.2. Merck 2019 Human Microbiome Business Regional Distribution
13.1.4. Product/ Service and Specification
13.1.5. Recent Developments & Business Strategy
13.1.6. Manufacturing Plant Footprint Analysis
13.2. Yakult
13.3. DuPont
13.4. Enterome Bioscience
13.5. ViThera Pharmaceuticals
13.6. Second Genome Inc.,
13.7. Vedanta BioScience
13.8. Microbiome Therapeutics LLC
13.9. Osel
13.10. Metabiomics Corporation
13.11. Others
To Get Premium Report Full Copy in Form of Single user or Multiple user@https://www.acumenresearchandconsulting.com/buy-now/0/2430
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
